Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.58 - $17.36 $35,049 - $44,806
-2,581 Reduced 6.39%
37,783 $594,000
Q4 2023

Feb 13, 2024

SELL
$10.11 - $16.54 $59,719 - $97,701
-5,907 Reduced 12.77%
40,364 $651,000
Q3 2023

Nov 14, 2023

SELL
$12.46 - $15.48 $177,916 - $221,038
-14,279 Reduced 23.58%
46,271 $588,000
Q2 2023

Aug 21, 2023

SELL
$13.28 - $15.96 $60,078 - $72,203
-4,524 Reduced 6.95%
60,550 $852,000
Q1 2023

May 09, 2023

BUY
$14.26 - $22.1 $169,565 - $262,791
11,891 Added 22.36%
65,074 $1.01 Million
Q4 2022

Feb 14, 2023

BUY
$14.85 - $19.04 $17,894 - $22,943
1,205 Added 2.32%
53,183 $871,000
Q3 2022

Nov 18, 2022

BUY
$12.38 - $20.23 $37,449 - $61,195
3,025 Added 6.18%
51,978 $962,000
Q2 2022

Aug 15, 2022

SELL
$9.11 - $13.98 $22,410 - $34,390
-2,460 Reduced 4.78%
48,953 $644,000
Q1 2022

May 16, 2022

SELL
$6.87 - $11.11 $28,730 - $46,462
-4,182 Reduced 7.52%
51,413 $477,000
Q4 2021

Feb 15, 2022

BUY
$7.7 - $37.13 $9,139 - $44,073
1,187 Added 2.18%
55,595 $543,000
Q3 2021

Nov 15, 2021

BUY
$26.46 - $37.15 $3,783 - $5,312
143 Added 0.26%
54,408 $1.85 Million
Q2 2021

Aug 16, 2021

SELL
$32.73 - $47.95 $129,348 - $189,498
-3,952 Reduced 6.79%
54,265 $1.99 Million
Q1 2021

May 18, 2021

BUY
$40.39 - $56.73 $21,972 - $30,861
544 Added 0.94%
58,217 $2.61 Million
Q4 2020

Feb 16, 2021

BUY
$51.77 - $66.18 $41,933 - $53,605
810 Added 1.42%
57,673 $3.29 Million
Q3 2020

Nov 17, 2020

BUY
$43.8 - $58.16 $19,885 - $26,404
454 Added 0.8%
56,863 $2.92 Million
Q2 2020

Aug 17, 2020

BUY
$37.05 - $65.03 $909,021 - $1.6 Million
24,535 Added 76.97%
56,409 $3.37 Million
Q1 2020

May 13, 2020

BUY
$33.63 - $69.4 $57,910 - $119,506
1,722 Added 5.71%
31,874 $1.31 Million
Q4 2019

Feb 14, 2020

BUY
$31.7 - $69.93 $19,273 - $42,517
608 Added 2.06%
30,152 $1.88 Million
Q3 2019

Nov 15, 2019

BUY
$19.95 - $38.85 $135,759 - $264,374
6,805 Added 29.93%
29,544 $1 Million
Q2 2019

Aug 14, 2019

BUY
$21.05 - $26.21 $188,860 - $235,156
8,972 Added 65.17%
22,739 $513,000
Q4 2018

Feb 13, 2019

BUY
$19.08 - $36.14 $7,517 - $14,239
394 Added 2.95%
13,767 $289,000
Q3 2018

Nov 14, 2018

BUY
$33.57 - $42.1 $58,076 - $72,833
1,730 Added 14.86%
13,373 $518,000
Q2 2018

Aug 14, 2018

SELL
$20.06 - $44.95 $22,206 - $49,759
-1,107 Reduced 8.68%
11,643 $458,000
Q1 2018

May 15, 2018

SELL
$20.04 - $29.71 $5,150 - $7,635
-257 Reduced 1.98%
12,750 $256,000
Q4 2017

Feb 14, 2018

BUY
$16.54 - $24.2 $215,135 - $314,769
13,007
13,007 $295,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.